Log in to save to my catalogue

Non‐nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, saf...

Non‐nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, saf...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3764307

Non‐nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability

About this item

Full title

Non‐nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability

Publisher

Switzerland: International AIDS Society

Journal title

Journal of the International AIDS Society, 2013-01, Vol.16 (1), p.1-n/a

Language

English

Formats

Publication information

Publisher

Switzerland: International AIDS Society

More information

Scope and Contents

Contents

Introduction
Human immunodeficiency virus (HIV) type‐1 non‐nucleoside and nucleoside reverse transcriptase inhibitors (NNRTIs) are key drugs of highly active antiretroviral therapy (HAART) in the clinical management of acquired immune deficiency syndrome (AIDS)/HIV infection.
Discussion
First‐generation NNRTIs, nevirapine (NVP), delavirdin...

Alternative Titles

Full title

Non‐nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3764307

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3764307

Other Identifiers

ISSN

1758-2652

E-ISSN

1758-2652

DOI

10.7448/IAS.16.1.18567

How to access this item